227 related articles for article (PubMed ID: 34026630)
1. Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer.
Zeng Y; Shi Y; Xu L; Zeng Y; Cui X; Wang Y; Yang N; Zhou F; Zhou Y
Front Oncol; 2021; 11():656172. PubMed ID: 34026630
[TBL] [Abstract][Full Text] [Related]
2. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
3. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis.
Ma W; Wang B; Zhang Y; Wang Z; Niu D; Chen S; Zhang Z; Shen N; Han W; Zhang X; Wei R; Wang C
Cancer Cell Int; 2019; 19():239. PubMed ID: 31528121
[TBL] [Abstract][Full Text] [Related]
5. A Regulatory Network Analysis of the Importance of USP15 in Breast Cancer Metastasis and Prognosis.
Ling J; Qin C; Li T; Wang B; Cai W; Ma L; Wang Y; Chen J; Xu F
J Oncol; 2022; 2022():1427726. PubMed ID: 36213818
[TBL] [Abstract][Full Text] [Related]
6. Independent prognostic implications of
Ma C; Luo H; Cao J; Gao C; Fa X; Wang G
J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291
[No Abstract] [Full Text] [Related]
7. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
8. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma.
Zhao H; Lu G
Front Genet; 2022; 13():905581. PubMed ID: 35754829
[No Abstract] [Full Text] [Related]
10. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
Front Oncol; 2021; 11():656509. PubMed ID: 34178642
[TBL] [Abstract][Full Text] [Related]
11. FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC.
Hu DM; Zhang WD; Shi ZE; Zhang MY; Li R; Wang QX; Ji XL; Qu YQ
Front Genet; 2022; 13():937069. PubMed ID: 36160018
[No Abstract] [Full Text] [Related]
12. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
13. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
14. SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer.
Dai W; Feng J; Hu X; Chen Y; Gu Q; Gong W; Feng T; Wu J
Cancer Cell Int; 2021 Feb; 21(1):106. PubMed ID: 33632211
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of prognostic value and immune infiltration of kindlin family members in non-small cell lung cancer.
Su X; Liu N; Wu W; Zhu Z; Xu Y; He F; Chen X; Zeng Y
BMC Med Genomics; 2021 May; 14(1):119. PubMed ID: 33934696
[TBL] [Abstract][Full Text] [Related]
16. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
Zhu H; Wang G; Zhu H; Xu A
J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
[No Abstract] [Full Text] [Related]
17. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
18. Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer.
Zheng X; Wang X; He Y; Ge H
Front Mol Biosci; 2022; 9():844618. PubMed ID: 35923467
[No Abstract] [Full Text] [Related]
19. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
20. The novel lncRNA PTTG3P is downregulated and predicts poor prognosis in non-small cell lung cancer.
Huang HT; Xu YM; Ding SG; Yu XQ; Wang F; Wang HF; Tian X; Zhong CJ
Arch Med Sci; 2020; 16(4):931-940. PubMed ID: 32542097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
